Viewing Study NCT02937818

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-03-01 @ 3:55 PM
Study NCT ID: NCT02937818
Status: COMPLETED
Last Update Posted: 2024-06-07
First Post: 2016-10-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Platinum Refractory Extensive-Stage Carcinoma, Small Cell Lung View
None Platinum Refractory Extensive-Stage Oat Cell Carcinoma of Lung View
None Platinum Refractory Extensive-Stage Oat Cell Lung Cancer View
None Platinum Refractory Extensive-Stage Small Cell Cancer Of The Lung View
None Platinum Refractory Extensive-Stage Small Cell Lung Cancer View